RFG Advisory’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,207
Closed -$40.3K 885
2024
Q4
$40.3K Buy
+10,207
New +$45.7K ﹤0.01% 755
2023
Q4
Sell
-12,609
Closed -$68.7K 671
2023
Q3
$68.7K Sell
12,609
-2,200
-15% -$17.6K ﹤0.01% 614
2023
Q2
$137K Sell
14,809
-13,141
-47% -$111K 0.01% 612
2023
Q1
$230K Buy
27,950
+706
+3% +$7.79K 0.01% 572
2022
Q4
$348K Buy
27,244
+7,076
+35% +$82.3K 0.02% 480
2022
Q3
$234K Buy
20,168
+7,900
+64% +$120K 0.01% 553
2022
Q2
$195K Sell
12,268
-1,988
-14% -$35.8K 0.01% 541
2022
Q1
$301K Sell
14,256
-209
-1% -$4.5K 0.02% 418
2021
Q4
$342K Buy
14,465
+48
+0.3% +$1.03K 0.02% 374
2021
Q3
$289K Sell
14,417
-795
-5% -$16.3K 0.02% 359
2021
Q2
$306K Buy
15,212
+4,812
+46% +$103K 0.03% 349
2021
Q1
$221K Buy
10,400
+12
+0.1% +$258 0.02% 406
2020
Q4
$219K Buy
10,388
+13
+0.1% +$253 0.03% 404
2020
Q3
$183K Buy
+10,375
New +$193K 0.03% 384
2019
Q1
Sell
-418,288
Closed -$6.73M 291
2018
Q4
$6.73M Buy
+418,288
New +$6.62M 1.65% 10

Other funds holding MPT

RFG Advisory's MPT Position: Q1 2025 in Review

RFG Advisory sold out of Medical Properties Trust (MPT) in Q1 2025, closing a stake of 10,207 shares — an estimated $40.3K sold.

RFG Advisory first reported a position in MPT in Q4 2018 and held it in 15 quarters. The position peaked at $6.73M in Q4 2018. 470 funds tracked by Wall St. Rank hold MPT as of Q1 2025.

  • RFG Advisory reported no remaining Medical Properties Trust position as of Q1 2025 after selling out during the quarter.
  • RFG Advisory sold 10,207 Medical Properties Trust shares in Q1 2025, an estimated $40.3K.
  • RFG Advisory first reported a position in Medical Properties Trust in Q4 2018 and held it in 15 quarters.
  • RFG Advisory's Medical Properties Trust position peaked at $6.73M in Q4 2018.
  • 470 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2025.

Based on RFG Advisory's 13F filing for Q1 2025, filed 9 Apr 2025.